Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 1
2019 1
2020 9
2021 6
2022 6
2024 3
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Prospective Validation of CAR-HEMATOTOX and a Simplified Version Predict Survival in Patients with Large B-Cell Lymphoma Treated with Anti-CD19 CAR T-Cells: Data from CART-SIE Study.
Stella F, Pennisi M, Chiappella A, Casadei B, Bramanti S, Ljevar S, Chiusolo P, Rocco AD, Tisi MC, Angelillo P, Cutini I, Martino M, Barone A, Bonifazi F, Santoro A, Sorà F, Novo M, Barbui AM, Russo D, Musso M, Grillo G, Krampera M, Olivieri J, Brunello L, Cavallo F, Massaia M, Arcaini L, Farina L, Zinzani P, Miceli R, Corradini P. Stella F, et al. Among authors: angelillo p. Transplant Cell Ther. 2025 Apr;31(4):240.e1-240.e9. doi: 10.1016/j.jtct.2025.01.888. Epub 2025 Jan 25. Transplant Cell Ther. 2025. PMID: 39870308 Free article.
Severe ICANS after CAR T-cell therapy and assessment of prevention with levetiracetam for seizure prophylaxis following CAR T-cell for DLBCL & PMBCL in Europe: a survey on behalf of the Cellular Therapy & Immunobiology Working Party (CTIWP) of the EBMT.
Angelillo P, Alarcon Tomas A, Campodonico E, Novak U, Gabellier L, Blau IW, Kwon M, Ram R, Forcade E, Besley C, Vucinic V, Kröger N, Corral LL, Vydra J, Ferrari S, von Tresckow B, Rubio MT, Hernani R, Sica S, Stölzel F, Rovira M, Wagner-Drouet E, Pérez-Simón JA, Castilla-Llorente C, Ferreri AJM, Hoogenboom JD, Sanchez Ortega I, Malard F, Kuball J, Ruggeri A. Angelillo P, et al. Bone Marrow Transplant. 2025 Jan;60(1):100-102. doi: 10.1038/s41409-024-02451-8. Epub 2024 Oct 25. Bone Marrow Transplant. 2025. PMID: 39455896 No abstract available.
Brexucabtagene autoleucel in-vivo expansion and BTKi refractoriness have a negative influence on progression-free survival in mantle cell lymphoma: Results from CART-SIE study.
Stella F, Chiappella A, Magni M, Bonifazi F, De Philippis C, Musso M, Cutini I, Ljevar S, Barbui AM, Farina M, Martino M, Massaia M, Grillo G, Angelillo P, Botto B, Patriarca F, Krampera M, Arcaini L, Tisi MC, Zinzani P, Sorà F, Bramanti S, Pennisi M, Carniti C, Corradini P. Stella F, et al. Among authors: angelillo p. Br J Haematol. 2025 Feb;206(2):644-651. doi: 10.1111/bjh.19961. Epub 2024 Dec 22. Br J Haematol. 2025. PMID: 39710966 Free PMC article.
Outcomes of CAR T-cells therapy in High-grade B-cell lymphomas compared to DLBCL: a weighted comparison analysis.
Dodero A, Ceparano G, Casadei B, Angelillo P, Bramanti S, Tisi MCC, Ljevar S, Stella F MD, Chiappella A, Botto B, Cutini I, Zanirato G, Chiusolo P, Barbui AM, Farina M, Di Rocco A, Grillo G, Olivieri J, Krampera M, Ladetto M, Guidetti A, Zinzani PL, Carniti C, Corradini P. Dodero A, et al. Among authors: angelillo p. Blood Adv. 2025 Aug 5:bloodadvances.2025016117. doi: 10.1182/bloodadvances.2025016117. Online ahead of print. Blood Adv. 2025. PMID: 40763273
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study.
Chiappella A, Casadei B, Chiusolo P, Di Rocco A, Ljevar S, Magni M, Angelillo P, Barbui AM, Cutini I, Dodero A, Bonifazi F, Tisi MC, Bramanti S, Musso M, Farina M, Martino M, Novo M, Grillo G, Patriarca F, Zacchi G, Krampera M, Pennisi M, Galli E, Martelli M, Ferreri AJM, Ferrari S, Saccardi R, Bermema A, Guidetti A, Miceli R, Zinzani PL, Corradini P. Chiappella A, et al. Among authors: angelillo p. Leukemia. 2024 May;38(5):1107-1114. doi: 10.1038/s41375-024-02213-x. Epub 2024 Mar 8. Leukemia. 2024. PMID: 38459167 Free PMC article.
Clonal hematopoiesis of indeterminate potential associates with higher risk of thromboembolism in severe COVID-19.
Bergonzi GM, Galimard JE, Aletti FM, Angelillo P, Mastaglio S, Erbella F, Palumbo D, Calori G, Querini PR, Tresoldi C, Fragasso G, De Cobelli F, Assanelli AA, Ciceri F, Della Porta MG, Ruggeri A, Bernardi M. Bergonzi GM, et al. Among authors: angelillo p. Haematologica. 2025 Sep 1;110(9):2214-2218. doi: 10.3324/haematol.2024.287128. Epub 2025 Mar 20. Haematologica. 2025. PMID: 40109188 Free PMC article. No abstract available.
Caring with compassion during COVID-19.
Renzi S, Fallanca F, Zangrillo A, Tresoldi M, Landoni G, Angelillo P, Pepe G, Pajoro U, Maestranzi G, Yacoub MR. Renzi S, et al. Among authors: angelillo p. Palliat Support Care. 2020 Aug;18(4):403-404. doi: 10.1017/S1478951520000577. Palliat Support Care. 2020. PMID: 32729440 No abstract available.
Marginal zone lymphoma with anti-factor H IgM and atypical hemolytic uremic syndrome successfully treated with odronextamab.
Ardissino G, Angelillo P, Mancuso MC, Griffini S, Grovetti E, Porcaro L, Ria T, Marktel S, Peyvandi F, Luminari S, Ferreri AJM, Merli M, Cugno M. Ardissino G, et al. Among authors: angelillo p. Haematologica. 2025 Sep 1;110(9):2235-2239. doi: 10.3324/haematol.2025.287532. Epub 2025 May 15. Haematologica. 2025. PMID: 40371898 Free PMC article. No abstract available.
29 results